论文部分内容阅读
为了更好地规范制药企业和医疗卫生专家之间,以及与中低等经济收入国家的政府和其他机构之间的合作,国际制药商协会联合会(The International Federation of Pharmaceutical Manufacturers and Associations,IFPMA)近期发布了一项关于继续医学教育活动的新规定。
In order to better regulate the cooperation between pharmaceutical companies and health professionals, as well as with governments and other institutions in low- and middle-income countries, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Recently released a new regulation on continuing medical education.